These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2521976)

  • 1. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
    Rogers WJ; Bourge RC; Papapietro SE; Wackers FJ; Zaret BL; Forman S; Dodge HT; Robertson TL; Passamani ER; Braunwald E
    Am J Cardiol; 1989 Mar; 63(9):503-12. PubMed ID: 2521976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
    Passamani E; Hodges M; Herman M; Grose R; Chaitman B; Rogers W; Forman S; Terrin M; Knatterud G; Robertson T
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):51B-64B. PubMed ID: 2889758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of time required for reperfusion (thrombolysis or angioplasty, or both) and location of acute myocardial infarction on left ventricular functional reserve capacity several months later.
    Little T; Crenshaw M; Liberman HA; Battey LL; Warner R; Churchwell AL; Eisner RL; Morris DC; Patterson RE
    Am J Cardiol; 1991 Apr; 67(9):797-805. PubMed ID: 1901437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
    TIMI Study Group
    N Engl J Med; 1989 Mar; 320(10):618-27. PubMed ID: 2563896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group.
    Gosselink AT; Liem AL; Reiffers S; Zijlstra F
    Clin Cardiol; 1998 Apr; 21(4):254-60. PubMed ID: 9562935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute myocardial infarction: immediate coronary angioplasty for failure or contra-indications of thrombolytic therapy. Apropos of a series of 100 cases].
    Mossard JM; Arbogast R; Roman S; Baruthio J; Germain P; Roul G; Kraenner C; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):469-75. PubMed ID: 1905914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study.
    Ribichini F; Steffenino G; Dellavalle A; Ferrero V; Vado A; Feola M; Uslenghi E
    J Am Coll Cardiol; 1998 Nov; 32(6):1687-94. PubMed ID: 9822097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Ellis SG; Lincoff AM; George BS; Kereiakes DJ; Ohman EM; Krucoff MW; Califf RM; Topol EJ
    Coron Artery Dis; 1994 Jul; 5(7):611-5. PubMed ID: 7952423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
    Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group.
    JAMA; 1988 Nov; 260(19):2849-58. PubMed ID: 2972848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study.
    Zaret BL; Wackers FJ; Terrin ML; Ross R; Weiss M; Slater J; Morrison J; Bourge RC; Passamani E; Knatterud G
    Am J Cardiol; 1992 Jan; 69(1):1-9. PubMed ID: 1729855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.
    Anderson JL; Becker LC; Sorensen SG; Karagounis LA; Browne KF; Shah PK; Morris DC; Fintel DJ; Mueller HS; Ross AM
    J Am Coll Cardiol; 1992 Oct; 20(4):753-66. PubMed ID: 1527286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Williams DO; Ruocco NA; Forman S
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):45B-50B. PubMed ID: 2959715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators.
    Chaitman BR; Thompson BW; Kern MJ; Vandormael MG; Cohen MB; Ruocco NA; Solomon RE; Braunwald E
    Am Heart J; 1990 Feb; 119(2 Pt 1):213-23. PubMed ID: 2105625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
    Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
    Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.